| Net loss | -14.61M |
| Depreciation and amortization | 3.49M |
| Contingent consideration and realignment accrual accretion | 29K |
| Reversal of contingent consideration accrual | |
| Provision for bad debt | 482K |
| Stock-based compensation | 109K |
| Decrease in accounts receivable | 4.64M |
| Decrease (increase) in unbilled costs | 16K |
| Decrease in income tax refund receivable | |
| Increase in other current assets | 1.27M |
| Increase in other long-term assets | 754K |
| Increase (decrease) in accounts payable | -761K |
| Increase in unearned contract revenue | -11K |
| (Decrease) increase in accrued salaries and bonus | |
| (Decrease) increase in other accrued expenses | -4.56M |
| Decrease in long-term liabilities | |
| Net cash provided by operating activities | -6.62M |
| Purchase of property and equipment | 0 |
| Net cash used in investing activities | 0 |
| Cash paid for repurchase of restricted shares | |
| Net cash used in financing activities | 0 |
| Net increase in cash and cash equivalents | -6.62M |
| Cash and cash equivalents – beginning | 8.31M |
| Cash and cash equivalents – ending | 1.69M |